Treatment options for post-transplant lymphoproliferative disorder and other Epstein-Barr virus-associated malignancies.
about
CAR T Cell Therapy: A Game Changer in Cancer TreatmentImmunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapyIntegrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection.Dendritic cells loaded with tumor B cells elicit broad immunity against murine gammaherpesvirus 68 but fail to prevent long-term latencyAn overview of the pathogenesis and natural history of post-transplant T-cell lymphoma (corrected and republished article originally printed in Leukemia & Lymphoma, June 2007; 48(6): 1237 - 1241).Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options.Burkitt lymphoma in Papua New Guinea--40 years on.EBV-associated post-transplantation B-cell lymphoproliferative disorder following allogenic stem cell transplantation for acute lymphoblastic leukaemia: tumor regression after reduction of immunosuppression--a case report.Post-transplant lymphoproliferative disorders and other malignancies after pediatric intestinal transplantation: incidence, clinical features and outcome.Antiherpesvirus activities of two novel 4'-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases.Use of CD107-based cell sorting ex vivo to enrich subdominant CD8+ T cells in culture.Clinical, phenotypic and genetic similarities and disparities between post-transplant and classical Hodgkin lymphomas with respect to therapeutic targets.
P2860
Q26822769-11387399-ACD6-4E83-89F9-C9505C0F70B4Q33289956-A8DE7C9B-21FC-4FBA-ACE7-2F68AC63AC2DQ33748511-7164A00E-CD39-4A6A-8020-2ED74A58C8B9Q34055365-B0503668-1C5D-4368-9D20-481034728CAFQ36929679-D4DAE18A-7383-4AE0-823C-088569500729Q37824825-952791C2-3A24-42A7-B4D8-E2E80D262F42Q39162920-AFC37966-BB3A-4DC6-8898-F432A1A586B9Q39994660-45CC7F4F-EB37-423D-B8BB-1DA0C8FCFCE8Q40245646-16CD9EFB-DBC8-4C78-90C9-FD687EFE886AQ42109765-F924A15F-2D4F-4355-8B11-711BA1B123B4Q53547204-639008E9-7CB7-4F62-B513-F2092454534EQ54724626-1CEED142-9B3E-47B1-8319-F66E9626F4BC
P2860
Treatment options for post-transplant lymphoproliferative disorder and other Epstein-Barr virus-associated malignancies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Treatment options for post-tra ...... virus-associated malignancies.
@ast
Treatment options for post-tra ...... virus-associated malignancies.
@en
type
label
Treatment options for post-tra ...... virus-associated malignancies.
@ast
Treatment options for post-tra ...... virus-associated malignancies.
@en
prefLabel
Treatment options for post-tra ...... virus-associated malignancies.
@ast
Treatment options for post-tra ...... virus-associated malignancies.
@en
P2860
P1433
P1476
Treatment options for post-tra ...... virus-associated malignancies.
@en
P2093
P2860
P304
P356
10.1111/J.0001-2815.2004.00227.X
P577
2004-04-01T00:00:00Z